(2S,5S,8S,11S,14S)-14,17-diamino-8-benzyl-2-(3-guanidinopropyl)-5-(hydroxymethyl)-4,7,10,13,17-pentaoxo-11-(3-ureidopropyl)-3,6,9,12-tetraazaheptadecan-1-oic acid

ID: ALA3633451

Chembl Id: CHEMBL3633451

PubChem CID: 122195274

Max Phase: Preclinical

Molecular Formula: C29H47N11O9

Molecular Weight: 693.76

Molecule Type: Protein

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)O

Standard InChI:  InChI=1S/C29H47N11O9/c30-17(10-11-22(31)42)23(43)37-18(8-4-13-36-29(34)49)24(44)39-20(14-16-6-2-1-3-7-16)25(45)40-21(15-41)26(46)38-19(27(47)48)9-5-12-35-28(32)33/h1-3,6-7,17-21,41H,4-5,8-15,30H2,(H2,31,42)(H,37,43)(H,38,46)(H,39,44)(H,40,45)(H,47,48)(H4,32,33,35)(H3,34,36,49)/t17-,18-,19-,20-,21-/m0/s1

Standard InChI Key:  LUFPXONZDNCKNJ-SXYSDOLCSA-N

Alternative Forms

  1. Parent:

    ALA3633451

    ---

Associated Targets(Human)

ANPEP Tchem Aminopeptidase N (863 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MME Tclin Neprilysin (838 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 693.76Molecular Weight (Monoisotopic): 693.3558AlogP: -4.45#Rotatable Bonds: 23
Polar Surface Area: 360.06Molecular Species: ZWITTERIONHBA: 10HBD: 13
#RO5 Violations: 2HBA (Lipinski): 20HBD (Lipinski): 17#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.86CX Basic pKa: 11.86CX LogP: -6.94CX LogD: -7.56
Aromatic Rings: 1Heavy Atoms: 49QED Weighted: 0.03Np Likeness Score: 0.18

References

1. Rosa M, Marcelo F, Calle LP, Rougeot C, Jiménez-Barbero J, Arsequell G, Valencia G..  (2015)  Influence of polar side chains modifications on the dual enkephalinase inhibitory activity and conformation of human opiorphin, a pain perception related peptide.,  25  (22): [PMID:26463133] [10.1016/j.bmcl.2015.09.071]

Source